Edition:
United Kingdom

Aduro Biotech Inc (ADRO.OQ)

ADRO.OQ on NASDAQ Stock Exchange Global Select Market

1.26USD
23 Aug 2019
Change (% chg)

$-0.08 (-5.97%)
Prev Close
$1.34
Open
$1.33
Day's High
$1.35
Day's Low
$1.25
Volume
59,940
Avg. Vol
103,144
52-wk High
$8.10
52-wk Low
$1.23

About

Aduro Biotech, Inc. is an immunotherapy company, which focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases, including cancer. The Company's product candidates from its Live, Attenuated, Double-Deleted (LADD) Listeria monocytogenes, Stimulator of Interferon Genes... (more)

Overall

Beta: --
Market Cap(Mil.): $762.55
Shares Outstanding(Mil.): 73.68
Dividend: --
Yield (%): --

Financials

  ADRO.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -1.57 -- --
ROI: -24.47 8.95 14.48
ROE: -42.02 10.09 15.78

BRIEF-Aduro Biotech And Novartis Present Results From Ongoing Phase 1B Study

* ADURO BIOTECH AND NOVARTIS PRESENT RESULTS FROM ONGOING PHASE 1B STUDY OF STING AGONIST ADU-S100 (MIW815) IN COMBINATION WITH ANTI-PD-1 MONOCLONAL ANTIBODY SPARTALIZUMAB (PDR001) IN PATIENTS WITH ADVANCED SOLID TUMORS OR LYMPHOMAS

02 Jun 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates